Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling

Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis

(2018) Biyan Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth

(2017) Hsin-Yuan Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Towards therapeutic advances in melanoma management: An overview

(2017) Swarnendra Singh et al.   LIFE SCIENCES

The licorice dietary component isoliquiritigenin chemosensitizes human uterine sarcoma cells to doxorubicin and inhibits cell growth by inducing apoptosis and autophagy via inhibition of m-TOR signaling

(2017) Li-Chun Lin et al.   Journal of Functional Foods

A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2

(2016) Shouhui Yang et al.   CANCER RESEARCH

Differentiation-inducing and anti-proliferative activities of isoliquiritigenin and all-trans-retinoic acid on B16F0 melanoma cells: Mechanisms profiling by RNA-seq

(2016) Xiaoyu Chen et al.   GENE

Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges

(2016) Antoine Millet et al.   MEDICINAL RESEARCH REVIEWS

Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells

(2016) Yanming Wang et al.   Recent Patents on Anti-Cancer Drug Discovery

The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN

(2016) Hiroshi Egawa et al.   Scientific Reports

Isoliquiritigenin Attenuates Adipose Tissue Inflammation in vitro and Adipose Tissue Fibrosis through Inhibition of Innate Immune Responses in Mice

(2016) Yasuharu Watanabe et al.   Scientific Reports

Update on melanoma epigenetics

(2015) Blanca de Unamuno et al.   CURRENT OPINION IN ONCOLOGY

Isoliquiritigenin as a cause of DNA damage and inhibitor of ataxia-telangiectasia mutated expression leading to G2/M phase arrest and apoptosis in oral squamous cell carcinoma

(2015) Shih-Min Hsia et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

The role of circulating miRNAs in multiple myeloma

(2015) Ji Zhang et al.   Science China-Life Sciences

Roles of miR-182 in sensory organ development and cancer

(2015) Qing Wei et al.   Thoracic Cancer

The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma

(2014) Muhammad Nauman Aftab et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Melanoma never says die

(2014) Nikolas K. Haass et al.   EXPERIMENTAL DERMATOLOGY

Malignant melanoma in elderly patients: biological, surgical and medical issues

(2014) Alessia E Russo et al.   Expert Review of Anticancer Therapy

Isoliquiritigenin Induces Apoptosis and Inhibits Xenograft Tumor Growth of Human Lung Cancer Cells by Targeting Both Wild Type and L858R/T790M Mutant EGFR

(2014) Sung Keun Jung et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation

(2014) JianFeng Xu et al.   Science China-Life Sciences

Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion

(2014) Hao Zheng et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor

(2013) Y Wang et al.   BRITISH JOURNAL OF CANCER

miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells

(2013) PETER DYNOODT et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Combination of liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell death through upregulating p53 and p21 in the A549 non-small cell lung cancer cells

(2013) YANLING ZHOU et al.   ONCOLOGY REPORTS

MicroRNA Expression Signatures in Solid Malignancies

(2012) Marco Galasso et al.   CANCER JOURNAL

Hypoxia-Inducible miR-210 Regulates the Susceptibility of Tumor Cells to Lysis by Cytotoxic T Cells

(2012) M. Z. Noman et al.   CANCER RESEARCH

The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor

(2012) Anne E. Powell et al.   CELL

miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis

(2011) Avital Gaziel-Sovran et al.   CANCER CELL

Interplay between HDAC3 and WDR5 Is Essential for Hypoxia-Induced Epithelial-Mesenchymal Transition

(2011) Min-Zu Wu et al.   MOLECULAR CELL

A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth

(2011) W Huang et al.   ONCOGENE

Epigenetic Regulation of MicroRNA Genes and the Role of miR-34b in Cell Invasion and Motility in Human Melanoma

(2011) Joseph Mazar et al.   PLoS One

A new understanding in the epidemiology of melanoma

(2010) Esther Erdei et al.   Expert Review of Anticancer Therapy

Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma

(2010) Carmit Levy et al.   MOLECULAR CELL

MicroRNAs and Cancer: Short RNAs Go a Long Way

(2009) Andrea Ventura et al.   CELL

Direct regulation of TWIST by HIF-1α promotes metastasis

(2008) Muh-Hwa Yang et al.   NATURE CELL BIOLOGY